CCAAT/enhancer‐binding protein delta (C/EBPδ) plays a minor role in renal host defense against uropathogenic Escherichia coli

J. Duitman, G.J.D. Teske, L.M. Butter, J.C. Leemans, S. Florquin, C.A. Spek. CCAAT/enhancer-binding protein delta (C/EBPd) plays a minor role in renal host defense against uropathogenic Escherichia coli. Transpl Infect Dis 2013. All rights reserved J. Duitman, G.J.D. Teske, L.M. Butter, J.C. Leemans, S. Florquin, C.A. Spek Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

[1]  T. van der Poll,et al.  CCAAT-enhancer binding protein delta (C/EBPδ) protects against Klebsiella pneumoniae-induced pulmonary infection: potential role for macrophage migration. , 2012, The Journal of infectious diseases.

[2]  S. Florquin,et al.  The Toll Interleukin-1 Receptor (IL-1R) 8/Single Ig Domain IL-1R-Related Molecule Modulates the Renal Response to Bacterial Infection , 2012, Infection and Immunity.

[3]  Qunyuan Zhang,et al.  Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo , 2012, Proceedings of the National Academy of Sciences.

[4]  T. van der Poll,et al.  CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner , 2012, Proceedings of the National Academy of Sciences.

[5]  S. Akira,et al.  Differential Role for c-Rel and C/EBPβ/δ in TLR-Mediated Induction of Proinflammatory Cytokines1 , 2009, The Journal of Immunology.

[6]  Y. Kuo,et al.  Renal Allograft Injury Is Associated with Urinary Tract Infection Caused by Escherichia coli Bearing Adherence Factors , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  A. Langone,et al.  Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers , 2005, Clinical transplantation.

[8]  D. Ramji,et al.  CCAAT/enhancer-binding proteins: structure, function and regulation. , 2002, The Biochemical journal.

[9]  M. Giral,et al.  Acute graft pyelonephritis and long-term kidney allograft outcome. , 2002, Kidney international.

[10]  H. Karakayalı,et al.  Major infectious complications after kidney transplantation. , 2001, Transplantation proceedings.

[11]  M. D. de Broe,et al.  Regeneration Processes in the Kidney after Acute Injury: Role of Infiltrating Cells , 1998, Nephron Experimental Nephrology.

[12]  Peter F. Johnson,et al.  Redundancy of C/EBPα, -β, and -δ in Supporting the Lipopolysaccharide-Induced Transcription of IL-6 and Monocyte Chemoattractant Protein-1 , 1998, The Journal of Immunology.

[13]  J. Tollemar,et al.  Urinary tract infections following renal transplantation. , 1998, Transplantation proceedings.

[14]  R. Rubin.  Infectious disease complications of renal transplantation. , 1993, Kidney international.

[15]  M. Baer,et al.  Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. , 1998, Journal of immunology.